Primary Site >> Liver Cancer
Gene >> TNFRSF18
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. PMID: 15781662 |
Ref: Hepatocellular carcinoma cell supernatants increase expansion and function of CD4(+)CD25(+) regulatory T cells. PMID: 17372588 Ref: Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells. PMID: 17390075 |
Ref: [Specific suppression in regulatory T cells by Foxp3 siRNA contributes to enhance the in vitro anti-tumor immune response in hepatocellular carcinoma patients]. PMID: 19727215 |
Ref: Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro. PMID: 20198327 Ref: DeltaNp73beta is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria. PMID: 20581467 Ref: Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses. PMID: 20586932 |
Ref: Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer. PMID: 22911397 Ref: Tim-3 expression defines regulatory T cells in human tumors. PMID: 23526963 |
Ref: GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cells ex vivo. PMID: 26587321 |
Ref: Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells. PMID: 26639061 |
Ref: Changes in DNA Methylation of Glucocorticoid-Induced Tumor Necrosis Factor Receptor and Its Ligand in Liver Transplantation. PMID: 28923633 |